U.S. Metals and Mining Stock News

Bank of America (BAC) just turned in its latest scorecard for Q1 2026, with recent quarterly revenue running at US$29.9b in Q4 2025 and basic EPS of about US$0.98 helping push trailing twelve month EPS to roughly US$3.86 on revenue of US$107.4b. Over the past year, revenue has moved from US$100.0b on a trailing basis in Q4 2024 to US$107.4b in Q4 2025, while trailing EPS stepped up from about US$3.23 to US$3.86, setting the backdrop for earnings that are described here as growing 14.6% over...

Eightco Holdings (ORBS) just posted its FY 2025 third quarter numbers, reporting revenue of US$5.3 million and a loss per share of US$0.58, alongside a trailing twelve month loss per share of US$2.42 on revenue of US$43.1 million. Over the past few reported quarters, revenue has moved from US$7.6 million in Q2 FY 2025 and US$9.9 million in Q1 FY 2025, while quarterly EPS has ranged from a loss of US$0.38 to a loss of US$0.87 and was US$1.81 in Q3 FY 2024. With the business still loss making...

EnCap Partners reduced its ownership stake in Kimbell Royalty Partners (NYSE:KRP) by more than 5%, shifting the mix of major holders in the partnership. Kimbell reported strong Q4 results, raised its cash distribution, and highlighted its royalty focused model during its latest update. The combination of a large holder trimming its position and fresh financial results gives investors new information on both capital flows around KRP units and the partnership’s recent operating...

Freedom Holding Corp. recently announced that it is considering an offering of its common stock in Kazakhstan, to be conducted outside the United States under Regulation S of the Securities Act of 1933. The potential Kazakhstan offering highlights the group’s intent to access additional international capital pools while broadening its investor base in a core operating market. Next, we’ll examine how this exploration of a Kazakhstan common stock offering could influence Freedom Holding’s...

JPMorgan Chase (JPM) has kicked off 2026 with investors weighing a recent stretch of strong top line and solid profitability, capped by Q4 2025 revenue of US$41.1b and basic EPS of US$4.64 on net income of US$12.7b. Over the past year, the bank has seen revenue move from US$40.1b in Q4 2024 to US$41.1b in Q4 2025, while trailing twelve month basic EPS sat at US$20.05 on net income of US$55.7b. This sets the stage for a results season where the focus is firmly on how comfortably margins are...

Wondering if Hasbro at US$92.75 is priced for more growth or already reflects the good news? This article walks through what the current share price might be implying about value. Over the last year the stock has returned 83.0%. There has been a 3.7% move over the past week, an 11.8% return year to date and a small 0.7% decline over the last 30 days that may interest readers watching for a pause or consolidation. Recent coverage has focused on Hasbro's ongoing efforts to sharpen its focus on...

Colgate-Palmolive Company ( NYSE:CL ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is one...

Northern Oil and Gas (NYSE:NOG) has released its 2025 ESG Report. The report includes an independent cybersecurity assessment and detailed climate risk analysis. The company states it has surpassed its carbon offset commitments for the reporting period. For readers tracking NYSE:NOG, the new ESG Report arrives with the stock at $25.68 and a mixed return profile. Shares are up 16.7% year to date and 22.5% over the past year, while the 3 year return shows an 11.9% decline and the 5 year...

Central Garden & Pet (NasdaqGS:CENT) has formed a nationwide pet distribution joint venture with Phillips Pet Food & Supplies, supported by external financing and asset integration efforts. The company is also rolling out a new sustainability initiative through Nylabone’s ocean friendly chew toys collection. These moves refocus the business toward branded products and bring environmental considerations further into its pet offerings. For investors watching the pet care sector, this joint...

Viavi Solutions (NasdaqGS:VIAV) has had its TTworkbench gPTP test suite and TestCenter M1 Appliance recognized as Avnu Certification Test Tool solutions. The recognition is part of the Avnu Alliance Time-Sensitive Networking Component Certification Program. This moves Viavi further into certification tooling for multi-vendor Time-Sensitive Networking across sectors such as automotive, industrial automation, and aerospace. For investors tracking networking and test equipment, this update...

Pagaya Technologies completed a $600 million AAA-rated personal loan asset-backed securities transaction. The deal brought four new institutional investors onto Pagaya's funding platform. The securitization closed during a period of market volatility, indicating continued access to capital markets for the company. For investors tracking NasdaqCM:PGY, this funding update sits alongside a share price of $13.01 and a mixed return profile. The stock is up 5.2% over the past week and 18.4% over...

Event context for IHS Holding (NYSE:IHS) IHS Holding (NYSE:IHS) has attracted investor attention after recent share price moves, with the stock showing a 0.6% return over the past month and 9.1% over the past 3 months. See our latest analysis for IHS Holding. While the recent 0.6% 1 month share price return looks modest, a 9.1% 3 month share price return alongside a 63.0% 1 year total shareholder return suggests momentum has been building over the past year despite a weaker 3 year total...

The United States market has recently experienced a robust climb, with a 4.4% increase in the last week and an impressive 32% rise over the past year, while earnings are projected to grow by 16% annually. In this context of strong market performance, identifying stocks that are estimated to be below their fair value can present opportunities for investors seeking potential growth at reasonable prices.

Over the last 7 days, the United States market has risen by 4.4%, contributing to a remarkable 32% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often reflect strong confidence from those most familiar with their operations and potential.

Over the last 7 days, the United States market has risen by 4.4%, and in the past year, it has climbed an impressive 32%, with earnings expected to grow by 16% annually. While penny stocks might seem like a relic from earlier market times, they continue to represent smaller or less-established companies that can offer significant value when chosen wisely. By focusing on those with strong financials and clear growth potential, investors can uncover opportunities in these niche stocks that may...

The United States market has shown impressive momentum, climbing 4.4% in the last week and rising 32% over the past year, with earnings projected to grow by 16% annually in the coming years. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can uncover promising opportunities for investors seeking to capitalize on these positive trends.

Wondering whether Selective Insurance Group at around US$80.90 is starting to look interesting on value, or still has more risk than reward baked into the price. The stock is up 2.1% over the last week and 5.9% over the last month, although year to date it shows a 3.1% decline and the 1 year return sits at a 6.5% loss, with a 3 year return of 11.4% loss and a 5 year return of 14.4% gain. Recent coverage has focused on the share price performance and how it compares with the wider insurance...

Wondering if Labcorp Holdings at around US$268.87 is still good value or starting to look fully priced, especially after a strong run? This article breaks that question down in plain terms. The stock has recently posted a 6.8% return year to date and 20.2% over the last year, with shorter term moves of 1.9% over 30 days and a slight 0.1% decline over 7 days that may have caught your attention. Recent news coverage has focused on Labcorp's position within the broader healthcare sector,...

Louisiana-Pacific (LPX) shares recently closed at $75.23. The total return over the past 3 months showed an 18.2% decline, and the year-to-date return was 8% lower for investors tracking performance. See our latest analysis for Louisiana-Pacific. Recent share price action has been choppy, with a 7.6% 7 day share price return sitting against a 90 day share price return decline of 18.2% and a weaker 1 year total shareholder return of 11.1%. If Louisiana-Pacific has you reassessing where to find...

CoreCivic Stock Moves After Recent Trading Performance CoreCivic (CXW) has drawn fresh attention after a recent move that leaves the stock at $19.95, with a roughly 10% gain over the past month and a small decline over the past year. See our latest analysis for CoreCivic. That recent 9.6% 1 month share price return sits alongside a 4.9% year to date share price return and a 3 year total shareholder return of about 120%, suggesting momentum has been built over time despite a weaker 1 year...

Johnson & Johnson (JNJ) has opened Q1 2026 with investors focused on how its recent run of earnings ties back to underlying profitability, after reporting Q4 2025 revenue of US$24.6 billion and basic EPS of US$2.10 alongside trailing twelve month EPS of US$11.13 and revenue of US$94.2 billion. Over the last few quarters the company has seen revenue range from US$21.9 billion in Q1 2025 to US$24.6 billion in Q4 2025, while quarterly basic EPS has moved between US$1.41 in Q4 2024 and US$4.57 in...

Cardinal Health released its 2026 Advanced Therapies Report, focusing on how advanced treatments are shifting toward community-based care. The report outlines how providers are rethinking care delivery models to widen patient access outside traditional hospital settings. Findings add new detail to Cardinal Health's role in advanced therapies beyond its previously covered radiopharmaceutical expansions. For investors watching Cardinal Health (NYSE:CAH), the new report lands at a time when...

Replimune Group, Inc. recently received a complete response letter from the FDA rejecting its Biologics License Application for RP1 plus nivolumab in advanced melanoma, despite earlier breakthrough therapy designation and priority review based on the IGNYTE trial data set. The company is publicly challenging what it calls inconsistent FDA processes and shifting review teams, highlighting broader tensions around accelerated approvals for oncology drugs. Next, we’ll examine how the FDA’s...

Earnings slide puts Lindsay (LNN) under closer investor scrutiny Lindsay (LNN) has moved into focus after reporting a year over year decline in both sales and net income for its second quarter and first half of fiscal 2026. The company posted second quarter sales of US$157.72 million and net income of US$12.05 million, compared with US$187.06 million and US$26.58 million a year earlier. This has prompted investors to reassess recent share performance. See our latest analysis for...